CMS’s announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals. This model has the potential to make changes to the entire pharma ecosystem.

Top 10 Takeaways: 2019 Medicare Physician Fee Schedule

Election Results Bring Change in Health Priorities

Democrats will take control of the House of Representatives in January. Republicans will retain control of the Senate. Split control of Congress will have important consequences for healthcare policy. This article examines the elections impact on the agenda.

A collection of primary source materials about laboratory diagnostics regulation and payment, including original analysis, Medicare rates, rulemakings, final determinations and other items of interest.

Democrats will take control of the House of Representatives in January 2019. Republicans will retain control of the Senate, widening their margin slightly. Split control of Congress will have important consequences for healthcare policy. This article takes a closer look at how the election is likely to impact the health policy agenda.

Webinar

Join the McDermott team for a complimentary webinar on changes to the pharma ecosystem. Our team will breakdown CMS’s recently proposed international pricing index model for Medicare Part B drugs and biologicals.